{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:41:52Z","timestamp":1792644112536,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2025-I2M-KJ-018"],"award-info":[{"award-number":["2025-I2M-KJ-018"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119381","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:48:19Z","timestamp":1790462899000},"page":"119381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of 177Lu-PSMA-MN4 as an improved PSMA-targeted radioligand with enhanced antitumor efficacy"],"prefix":"10.1016","volume":"320","author":[{"given":"Peishang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manchao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmiao","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuechen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6534-3627","authenticated-orcid":false,"given":"Kai","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangsheng","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119381_bib1","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/14737140.2025.2597529","article-title":"Economic and disease burden of prostate cancer in expanded BRICS nations: systematic analysis of global burden of disease study 1990 - 2021","volume":"26","author":"Satapathy","year":"2026","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.ejmech.2026.119381_bib2","article-title":"Characteristics and therapeutic resistance mechanisms of the prostate cancer immune microenvironment: a comprehensive analysis from bench to clinic","volume":"17","author":"Li","year":"2026","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119381_bib3","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1080\/14737159.2016.1243057","article-title":"Prostate specific membrane antigen (PSMA) ligands for diagnosis and therapy of prostate cancer","volume":"16","author":"Barrio","year":"2016","journal-title":"Expert Rev. Mol. Diagn"},{"key":"10.1016\/j.ejmech.2026.119381_bib4","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3389\/fonc.2018.00653","article-title":"New prostate cancer targets for diagnosis, imaging, and therapy: focus on prostate-specific membrane antigen","volume":"8","author":"Cimadamore","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2026.119381_bib5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/med.21508","article-title":"Targeting prostate cancer: Prostate-specific membrane antigen based diagnosis and therapy","volume":"39","author":"W\u00fcstemann","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2026.119381_bib6","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1158\/1055-9965.EPI-13-0668","article-title":"Prostate-specific membrane antigen protein expression in tumor tissue and risk of lethal prostate cancer","volume":"22","author":"Kasperzyk","year":"2013","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.ejmech.2026.119381_bib7","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2025710119","article-title":"Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells","volume":"119","author":"Bakht","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2026.119381_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-024-02041-6","article-title":"Radiopharmaceuticals and their applications in medicine","volume":"10","author":"Zhang","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2026.119381_bib9","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","article-title":"Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer","volume":"385","author":"Sartor","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.119381_bib10","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.2967\/jnumed.122.265155","article-title":"Prognostic value of End-of-Treatment PSMA PET\/CT in patients treated with (177)Lu-PSMA radioligand therapy: a retrospective, single-center analysis","volume":"64","author":"Murthy","year":"2023","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejmech.2026.119381_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MNM.0000000000000606","article-title":"Post-therapeutic dosimetry of 177Lu-DKFZ-PSMA-617 in the treatment of patients with metastatic castration-resistant prostate cancer","volume":"38","author":"Yadav","year":"2017","journal-title":"Nucl. Med. Commun."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119381_bib12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.4103\/aja2025103","article-title":"177Lu-PSMA for prostate cancer: progress, challenges and future perspectives","volume":"28","author":"Xi","year":"2026","journal-title":"Asian J. Androl."},{"key":"10.1016\/j.ejmech.2026.119381_bib13","doi-asserted-by":"crossref","first-page":"Op2501161","DOI":"10.1200\/OP-25-01161","article-title":"Efficacy and safety of 177Lu-PSMA-617 in elderly patients with metastatic castration-resistant prostate cancer","author":"Sentana-Lledo","year":"2026","journal-title":"JCO Oncol. Pract."},{"key":"10.1016\/j.ejmech.2026.119381_bib14","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1021\/acs.jmedchem.5b01210","article-title":"Linker modification strategies to control the prostate-specific membrane antigen (PSMA)-Targeting and pharmacokinetic properties of DOTA-Conjugated PSMA inhibitors","volume":"59","author":"Bene\u0161ov\u00e1","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119381_bib15","doi-asserted-by":"crossref","first-page":"914","DOI":"10.2967\/jnumed.114.147413","article-title":"Preclinical evaluation of a tailor-made DOTA-Conjugated PSMA inhibitor with optimized linker moiety for imaging and Endoradiotherapy of prostate cancer","volume":"56","author":"Bene\u0161ov\u00e1","year":"2015","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejmech.2026.119381_bib16","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1021\/acs.molpharmaceut.2c01101","article-title":"Improve the biodistribution with bulky and lipophilic modification strategies on lys-urea-glu-based PSMA-Targeting radiotracers","volume":"20","author":"Cai","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2026.119381_bib17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1021\/acs.molpharmaceut.4c00974","article-title":"Novel radiotheranostic ligands targeting prostate-specific membrane antigen based on dual linker approach","volume":"22","author":"Kazuta","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2026.119381_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s41181-024-00237-3","article-title":"A novel PSMA-targeting tracer with highly negatively charged linker demonstrates decreased salivary gland uptake in mice compared to [(68)Ga]Ga-PSMA-11","volume":"9","author":"Huang","year":"2024","journal-title":"EJNMMI Radiopharm Chem"},{"key":"10.1016\/j.ejmech.2026.119381_bib19","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1021\/acs.molpharmaceut.8b00499","article-title":"Effects of linker modification on tumor-to-kidney contrast of (68)Ga-Labeled PSMA-targeted imaging probes","volume":"15","author":"Kuo","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2026.119381_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115966","article-title":"A systematic review on the current status of PSMA-targeted imaging and radioligand therapy","volume":"263","author":"Capasso","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119381_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202505128","article-title":"Linker manipulation with Beta(3)-Amino acids potentiates the efficacy and safety of PSMA radiopharmaceuticals","volume":"15","author":"Gao","year":"2026","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.ejmech.2026.119381_bib22","doi-asserted-by":"crossref","first-page":"6832","DOI":"10.1021\/acs.jmedchem.5c00401","article-title":"Preclinical evaluation and first-in-human PET Study of Al(18)F-Labeled biphenyl-based dimeric PSMA tracers","volume":"68","author":"Chen","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119381_bib23","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s00259-024-07046-5","article-title":"Preliminary evaluation of a novel PSMA-targeting radiopharmaceutical [(68)Ga]Ga\/[(177)Lu]Lu-NYM032 for theranostic use in prostate cancer","volume":"52","author":"Fu","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejmech.2026.119381_bib24","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1007\/s11427-025-3223-4","article-title":"Chemical adaptation: bridging synthetic chemistry with drug development","volume":"69","author":"Ding","year":"2026","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.ejmech.2026.119381_bib25","doi-asserted-by":"crossref","first-page":"7077","DOI":"10.1021\/acsomega.4c10142","article-title":"Structure-Activity relationships and biological insights into PSMA-617 and its derivatives with modified lipophilic linker regions","volume":"10","author":"Sch\u00e4fer","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2026.119381_bib26","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.nucmedbio.2016.08.006","article-title":"Radiolabeled enzyme inhibitors and binding agents targeting PSMA: effective theranostic tools for imaging and therapy of prostate cancer","volume":"43","author":"Pillai","year":"2016","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ejmech.2026.119381_bib27","first-page":"579","article-title":"Detection of prostate-specific membrane antigen expressing cells in blood obtained from renal cancer patients: a potential biomarker of vascular invasion","volume":"24","author":"de la Taille","year":"2000","journal-title":"Cancer Detect. Prev."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119381_bib28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2174\/157340720903140119151919","article-title":"The evolution of peptide synthesis: from early days to small molecular machines","volume":"9","author":"Mollica","year":"2014","journal-title":"Curr. Bioact. Compd."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426008263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426008263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:24:19Z","timestamp":1792643059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426008263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":28,"alternative-id":["S0223523426008263"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119381","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of 177Lu-PSMA-MN4 as an improved PSMA-targeted radioligand with enhanced antitumor efficacy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119381","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119381"}}